Department of Pediatrics and Inherited Metabolic Disorders


DMP Diagnostic Laboratories carry out specialized laboratory examinations for the diagnosis and monitoring of patients in the field of biochemical genetics and related fields, screening of hereditary metabolic disorders in newborns born in cooperating maternity hospitals and provide continuous emergency service for selected statim examinations including medical consulting activities.

On January 1, 2022, a pilot screening program for spinal muscular atrophy (SMA) and the group of severe combined immunodeficiency (SCID) diseases was launched as part of newborn screening, the laboratory examination is carried out using the real-time quantitative polymerase chain reaction (PCR) method (QR-PCR) . The rules for the implementation of the SMA/SCID pilot screening program are defined in the appendix to the Ministry of Health Bulletin No. 6/2016 Methodological instructions for ensuring newborn laboratory screening and follow-up care, details of the project are given here.

As of June 1, 2022, a pilot program to examine vitamin B12 deficiency in newborns will be launched as part of the newborn screening in four selected maternity hospitals in Prague. Details and consent to participate downloadable here.

Detailed information on neonatal screening is provided at

Complete information on the services offered by DMP Diagnostic Laboratories is available in the current version Metabolic manuals:

DMP Biochemical Laboratory
DMP Enzymological Laboratory
DNA Diagnostic Laboratory of DMP
Laboratory of tissue cultures DMP
Sequencing Center
Laboratory for the Study of Mitochondrial Disorders
Informed consents for medical purposes
Do NOT follow this link or you will be banned from the site!